-

American Heart Association (AHA) Scientific Sessions Highlights Report 2025: Indications, Companies, and Therapies Focus on GLP-1RAs, Hyperlipidemia, Heart Failure, Pulmonary Arterial Hypertension - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "American Heart Association (AHA): Scientific Sessions 2025 Highlights" report has been added to ResearchAndMarkets.com's offering.

AHA 2025 took place in New Orleans, Louisiana, between 7-10 November 2025.

The American Heart Association (AHA) Scientific Sessions is an annual, four-day conference that brings together cardiovascular healthcare professionals from around the world to share the latest advances, research, and guidelines in heart and vascular medicine.

The cardiovascular & metabolic team attended industry-sponsored and scientific sessions where key therapies were featured, the contents of which were analyzed to create this AHA 2025 Highlights report.

Report Scope

Indications, companies, and therapies discussed:

GLP-1RAs

  • Novo Nordisk - Semaglutide
  • Viking Therapeutics - VK2735

Hyperlipidemia

  • SHR-1918

Heart Failure

  • BacNav

Pulmonary Arterial Hypertension

  • Satralizumab

And more!

Reasons to Buy

This report provides analysis on key presentations from the conference, and what they mean for your strategy, covering disease areas such as Obesity, Heart Failure, Pulmonary Arterial Hypertension, Dyslipidemia, and more.

Inside the report you'll find:

  • Emerging trends in cardiovascular and metabolic indications
  • Insights into the disease areas that took precedence at the conference
  • Key takeaways from headline sessions and late-breaking data
  • Clinical and commercial implications of notable presentations

Key Topics Covered:

1. Conference Overview

2. Industry Session Overview

3. Conference Analysis by Key Therapy

4. Key Presentations

  • GLP-1RAs
  • Hyperlipidemia
  • Heart Failure
  • Pulmonary Arterial Hypertension

5. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/vrrtrg

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Industry:

Research and Markets

Release Versions
English

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Computer System Validation (CSV) Training Course: Regulations Impacting Your Systems and Hands-on Practice Writing Validation Documents (Jan 27th - Jan 29th, 2026 & On-Demand) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Computer System Validation (CSV) Training Course (Jan 27th - Jan 29th, 2026)" training has been added to ResearchAndMarkets.com's offering. A course designed to completely immerse you in computer system validation. This course delivers comprehension of the regulations impacting your systems and hands-on practice writing validation documents. You will leave ready to lead efficient, effective, inspection- ready validation projects. Registration Includes: Checklist of...

Understanding Medical Device Regulatory Pathways - 510(k), PMA & Exemptions Webinar - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Understanding Medical Device Regulatory Pathways - 510(k), PMA & Exemptions (January 15, 2026)" training has been added to ResearchAndMarkets.com's offering. This expert-led 3-hour webinar provides a comprehensive introduction to the key regulatory pathways for medical device submissions in the US market. The regulation and control of new or substantially changed medical devices for sale in the US is based on the 510(k), PMA or DeNovo submission process. This w...

Medical Devices: Section 522 of the Federal Food, Drug, and Cosmetic Act (FD&C Act) Course: Developing Effective Post Market Surveillance and Complaint Handling Systems Training - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Medical Devices: Developing Effective Post Market Surveillance and Complaint Handling Systems Course (Jan 22nd - Jan 23rd, 2026)" training has been added to ResearchAndMarkets.com's offering. What are U.S. FDA CGMP expectations/requirements for Post Market Surveillance and Complaint Handling? This seminar will examine Section 522 of the Federal Food, Drug, and Cosmetic Act (FD&C Act), as well as appropriate articles / Annexes of the EU's MDR, which require manu...
Back to Newsroom